Washington, D.C. (April 5, 2017) – The Biotechnology Innovation Organization (BIO) announced today its selection of Congresswoman Kyrsten Sinema (D-AZ) as a 2017 Legislator of the Year. Congresswoman Sinema will receive the award in conjunction with BIO’s Legislative Day Fly-In.
The Arizona Bioindustry Association (AZBio) together with 42 other state bioindustry associations submited comments to the Centers for Medicare & Medicaid Services’ (CMS’s) Center for Medicare and Medicaid Innovation (CMMI) Medicare Part B Drug Payment Proposed Rule, released March 8, 2016.Continue reading
Each month, BIO provides the latest updates, issues and poll data on issues affecting our bioscience industry at the national level. Here’s what happened in February 2016.Continue reading
Medical device innovators got good news on December 18th as Congress passed a two-year moratorium on a tax the industry said was limiting its growth. Companies and industry backers in Arizona and around the country have worked for years to repeal the 2.3 percent tax on revenue from medical device sales. Continue reading
Andrew Fish, executive director of AdvaMedDx, issued the following statement on today’s House Energy & Commerce Health Subcommittee hearing on the regulation of diagnostic tests and laboratory operations:
The Washington Update for CSBA is provided to AZBio Members as an update on issues that affect our industry at the nation’s capitol
The latest updates from Capitol Hill as provided by BIO and Republic Consulting Group.Continue reading